Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
US11007252B2 · kind B2 · utility
3Cited by
24References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2018 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Jun 5, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/703
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.